Skip Nav Destination
Emicizumab, a bispecific antibody recognizing coagulation factors IX and X: how does it actually compare to factor VIII?
First-in-human response of BCL-2 inhibitor venetoclax in T-cell prolymphocytic leukemia
Issue Archive
December 7 2017
In this Issue
Table of Contents
INSIDE BLOOD COMMENTARIES
PLENARY PAPER
PERSPECTIVE
Emicizumab, a bispecific antibody recognizing coagulation factors IX and X: how does it actually compare to factor VIII?
Clinical Trials & Observations
BLOOD SPOTLIGHT
REVIEW ARTICLES
HOW I TREAT
CLINICAL TRIALS AND OBSERVATIONS
First-in-human response of BCL-2 inhibitor venetoclax in T-cell prolymphocytic leukemia
Clinical Trials & Observations
Brief Report
Bernd Boidol,Christoph Kornauth,Emiel van der Kouwe,Nicole Prutsch,Lukas Kazianka,Sinan Gültekin,Gregor Hoermann,Marius E. Mayerhoefer,Georg Hopfinger,Alexander Hauswirth,Michael Panny,Marie-Bernadette Aretin,Bernadette Hilgarth,Wolfgang R. Sperr,Peter Valent,Ingrid Simonitsch-Klupp,Richard Moriggl,Olaf Merkel,Lukas Kenner,Ulrich Jäger,Stefan Kubicek,Philipp B. Staber
IMMUNOBIOLOGY AND IMMUNOTHERAPY
LYMPHOID NEOPLASIA
PLATELETS AND THROMBOPOIESIS
RED CELLS, IRON, AND ERYTHROPOIESIS
THROMBOSIS AND HEMOSTASIS
LETTER TO BLOOD
BLOOD WORK
-
Cover Image
Cover Image
Fluorescence microscopy image of a peripheral blood smear from hagfish (Myxine glutinosa), the oldest surviving class of vertebrates, shows von Willebrand factor (VWF)–positive thrombocytes (red) surrounded by VWF-negative erythrocytes and spindle cells. The punctate pattern of staining suggests that hagfish VWF is stored in cytoplasmic granules. See the article by Grant et al on page 2548.
- PDF Icon PDF LinkFront Matter
- PDF Icon PDF LinkTable of Contents
- PDF Icon PDF LinkBack Matter
- PDF Icon PDF LinkEditorial Board
Advertisement intended for health care professionals
Email alerts
Advertisement intended for health care professionals